期刊文献+

郭志强教授经验方外治宫颈炎的回顾性研究 被引量:3

External treatment of cervicitis with Professor GUO Zhi-qiang's empirical formulas
原文传递
导出
摘要 目的观察郭志强教授经验方治疗宫颈炎的疗效。方法对115例郭志强教授治疗的宫颈炎患者进行回顾性分析,观察带下病证型分布情况,比较中药治疗带下病各证型的疗效,观察中药治疗宫颈糜烂的临床疗效及性生活出血改善情况。结果 115例患者中湿热下注证者57例,占49.57%;肾阳亏虚证者占29例,占25.22%,肾阴亏虚证者13例,占11.30%;脾虚湿困证者16例,占13.91%。中药治疗湿热下注证痊愈20例、显效16例、有效14例、无效7例,治疗肾阳亏虚证痊愈3例、显效3例、有效9例、无效14例,治疗肾阴亏虚证痊愈1例、显效2例、有效4例、无效6例,治疗脾虚湿困证痊愈2例、显效2例、有效6例、无效6例,经验方治疗不同证型带下病的疗效比较差异有统计学意义(P<0.05),治疗湿热下注证的带下病患者总有效率最高。治疗宫颈糜烂临床显效36例,有效59例,总有效率为82.61%。仅1例患者仍出现性生活出血,其余9例均未再出现性生活出血。结论带下病患者中以湿热下注证为多见,郭志强教授经验方治疗湿热下注证型疗效最好,对于宫颈糜烂及性生活出血有一定的临床疗效。 Objective To observe the curative effect of Professor GUO Zhi-qiang's empirical formulas on cervicitis. Methods The patients with cervicitis (n=115) treated by Professor GUO Zhi-qiang were analyzed retrospectively, and the distribution of syndrome types of vaginal discharge was observed. The curative effect of Chinese medicinal for treating different types of vaginal discharge was compared, and the curative effects of Chinese medicinal for treating cervicitis and sexual bleeding were observed. Results Among 115 patients, there were 57 with syndrome of damp-heat pouring down into lower energizer (49.57%), 29 with syndrome of kidney yang deficiency (25.22%), 13 with syndrome of kidney yin deficiency (11.30%), and 16 with syndrome of spleen deficiency with dampness encumbrance (13.91%). After treatment with Chinese medicinal, there were 20 cases cured, 16 with obvious effects, 14 with effects and 7 without effects in patients with syndrome of damp-heat pouring down into lower energizer. There were 3 cases cured, 3 with obvious effects, 9 with effects and 14 without effects in patients with syndrome of kidney yang deficiency. There were 1 case cured, 2 with obvious effects, 4 with effects and 6 without effects in patients with syndrome of kidney yin deficiency. There were 2 cases cured, 2 with obvious effects, 6 with effects and 6 without effects in patients with syndrome of spleen deficiency with dampness encumbrance. The empirical formulas had different curative effects for different types of vaginal discharge (P〈0.05), and the total effective rate was highest in patients with syndrome of damp-heat pouring down into lower energizer. There were 36 cases with obvious effects and 59 with effects in patients with cervical erosion, and the total effective rate was 82.61%. There was only one case with sexual bleeding and other 9 without once more. Conclusion The syndrome of damp-heat pouring down into lower energizer is common in the patients with vaginal discharge, and on which the empirical formulas have the best curative effect. GUO Zhi-qiang' s empirical formulas also have some curative effect on cervical erosion and sexual bleeding.
出处 《北京中医药大学学报(中医临床版)》 2012年第3期18-21,共4页 Journal of Beijing University of Traditional Chinese Medicine
基金 北京市中医管理局北京中医药"薪火传承3+3工程"
关键词 带下病 宫颈炎 回顾性研究 经验方 vaginal discharge cervicitis retrospective study empirical formulas
  • 相关文献

参考文献5

二级参考文献23

  • 1Hildesheim A, Herrero R, Wacholder S, et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial [J]. JAMA, 2007,298(7) : 743-753.
  • 2Steller MA, Gurski K J, Murakami M, et al. Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7 [J]. Clin Cancer Res, 1998,4(9): 2103-2109.
  • 3Muderspach L, Wilczynski S, Roman L, et al. A phase Ⅰ trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive [J]. Clin Cancer Res, 2000, (9): 3406-3416.
  • 4Qian X, Lu Y, Liu Q, Chen K, Zhao Q, Song J. Prophylactic, therapeutic and anti-metastatic effects of an HPV-16mE6Delta/mE7/TBhsp70Deha fusion protein vaccine in an animal model [J]. Immunol Lett, 2006, 102(2): 191-201.
  • 5Einstein MH, Kadish AS, Burk RD, et al. Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III [J]. Gynecol Oncol, 2007,106 (3): 453-460.
  • 6Chen X, Chang CH, Goldenberg DM. Novel strategies for improved cancer vaccines [J]. Expert review of vaccines,2009,8(5): 567-576.
  • 7Kaufmann AM, Nieland JD, Jochmus I, et al. Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3) [J]. Int J Cancer, 2007,121 (12) : 2794-2800.
  • 8Brulet JM, Maudoux F, Thomas S, et al. DNA vaccine encoding' endosome-targeted human papillomavirus type 16 E7 protein generates CD4^+ T ceil-dependent protection [J]. Eur J Immunol, 2007,37(2) : 376-384.
  • 9Hung CF, Tsai YC, He L, Wu TC. DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4^+ T-cell immune responses and enhances vaccine potency [J]. Mol Ther,2007,15(6): 1211-1219.
  • 10Brinkman JA, Xu X, Kast WM. The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors [J]. Vaccine, 2007,25(17): 3437-3444.

共引文献829

同被引文献29

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部